MedPath

effect of Morus nigra L. on diabetic

Phase 2
Conditions
Diabetes mellitus
E10-E14
Diabetes mellitus.
Registration Number
IRCT201407163227N5
Lead Sponsor
Vice chancellor for research, Arak University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

inclusion criteria included: Patients over 18 years; Type II diabetes for at least a year; Patients with blood levels of glycosylated hemoglobin of 7 to 9%; Recourse to the diabetes clinic in Khomeini city; consent to participate in research
Exclusion criteria included: Pregnant women or those who are trying to conceive; lactating women; patients with physical and mental disorders; Patients who use herbal medicines, nearly as continuous doesn; Patients who have a special diet; Patients who use drugs addressing specific; diabetics insulin consume; patients younger than 18 years; having severe stress in the past 8 weeks; allergic to herbal medicines; Patients who have a need to change the amount of medicine; Patients who need to change their weight; Patients who need to change the quality of life.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1C. Timepoint: Before intervention and 3 Months after intervention. Method of measurement: blood test and biosystem kit.
Secondary Outcome Measures
NameTimeMethod
Fasting blood sugar. Timepoint: Before intervention and 3 months after intervention. Method of measurement: blood test and Glucose (GOD) Kit.
© Copyright 2025. All Rights Reserved by MedPath